Literature DB >> 7761462

Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2.

T Pineau1, P Fernandez-Salguero, S S Lee, T McPhail, J M Ward, F J Gonzalez.   

Abstract

Cytochrome P450 1A2 (CYP1A2) is a constitutively expressed hepatic enzyme that is highly conserved among mammals. This protein is primarily involved in oxidative metabolism of xenobiotics and is capable of metabolically activating numerous procarcinogens including aflatoxin B1, arylamines, heterocyclic amine food mutagens, and polycylic aromatic hydrocarbons. Expression of CYP1A2 is induced after exposure to certain aromatic hydrocarbons (i.e., 2,3,7,8-tetrachlorodibenzo-p-dioxin). Direct evidence for a role of CYP1A2 in any physiological or developmental pathway has not been documented. We now demonstrate that mice homozygous for a targeted mutation in the Cyp1a-2 gene are nonviable. Lethality occurs shortly after birth with symptoms of severe respiratory distress. Mutant neonates display impaired respiratory function associated with histological signs of lung immaturity, lack of air in alveoli at birth, and changes in expression of surfactant apoprotein in alveolar type II cells. The penetrance of the phenotype is not complete (19 mutants survived to adulthood out of 599 mice). Surviving animals, although lacking expression of CYP1A2, appear to be normal and are able to reproduce. These findings establish that CYP1A2 is critical for neonatal survival by influencing the physiology of respiration in neonates, thus offering etiological insights for neonatal respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761462      PMCID: PMC41863          DOI: 10.1073/pnas.92.11.5134

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Cytochromes P450 NMa, NMb (2G1), and LM4 (1A2) are differentially expressed during development in rabbit olfactory mucosa and liver.

Authors:  X Ding; H M Peng; M J Coon
Journal:  Mol Pharmacol       Date:  1992-12       Impact factor: 4.436

2.  Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene.

Authors:  V L Tybulewicz; M L Tremblay; M E LaMarca; R Willemsen; B K Stubblefield; S Winfield; B Zablocka; E Sidransky; B M Martin; S P Huang
Journal:  Nature       Date:  1992-06-04       Impact factor: 49.962

3.  Simplified mammalian DNA isolation procedure.

Authors:  P W Laird; A Zijderveld; K Linders; M A Rudnicki; R Jaenisch; A Berns
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

Review 4.  The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.

Authors:  D R Nelson; T Kamataki; D J Waxman; F P Guengerich; R W Estabrook; R Feyereisen; F J Gonzalez; M J Coon; I C Gunsalus; O Gotoh
Journal:  DNA Cell Biol       Date:  1993 Jan-Feb       Impact factor: 3.311

5.  Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens.

Authors:  T Shimada; C H Yun; H Yamazaki; J C Gautier; P H Beaune; F P Guengerich
Journal:  Mol Pharmacol       Date:  1992-05       Impact factor: 4.436

6.  Comparison of the flanking regions and introns of the mouse 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes.

Authors:  F J Gonzalez; S Kimura; D W Nebert
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

Review 7.  The 1992 Bernard B. Brodie Award Lecture. Bioactivation and detoxication of toxic and carcinogenic chemicals.

Authors:  F P Guengerich
Journal:  Drug Metab Dispos       Date:  1993 Jan-Feb       Impact factor: 3.922

8.  Estradiol metabolism by complementary deoxyribonucleic acid-expressed human cytochrome P450s.

Authors:  T Aoyama; K Korzekwa; K Nagata; J Gillette; H V Gelboin; F J Gonzalez
Journal:  Endocrinology       Date:  1990-06       Impact factor: 4.736

9.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality.

Authors:  E Li; T H Bestor; R Jaenisch
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

Review 10.  Cytochrome P450: progress and predictions.

Authors:  M J Coon; X X Ding; S J Pernecky; A D Vaz
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

View more
  12 in total

1.  Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development.

Authors:  J V Schmidt; G H Su; J K Reddy; M C Simon; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.

Authors:  Chi Chen; Xiaochao Ma; Michael A Malfatti; Kristopher W Krausz; Shioko Kimura; James S Felton; Jeffrey R Idle; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2007-02-06       Impact factor: 3.739

3.  Urinary metabolite profiling reveals CYP1A2-mediated metabolism of NSC686288 (aminoflavone).

Authors:  Chi Chen; Linghua Meng; Xiaochao Ma; Kristopher W Krausz; Yves Pommier; Jeffrey R Idle; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2006-06-14       Impact factor: 4.030

4.  Inhibitory effects of wogonin on catalytic activity of cytochrome P450 enzyme in human liver microsomes.

Authors:  Tingting Li; Ning Li; Qinglong Guo; Hui Ji; Di Zhao; Shan Xie; Xiaonan Li; Zhixia Qiu; Deen Han; Xijing Chen; Qidong You
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-06-29       Impact factor: 2.441

5.  Hyalinosis and Ym1/Ym2 gene expression in the stomach and respiratory tract of 129S4/SvJae and wild-type and CYP1A2-null B6, 129 mice.

Authors:  J M Ward; M Yoon; M R Anver; D C Haines; G Kudo; F J Gonzalez; S Kimura
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

6.  Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice.

Authors:  Yasushi Matsuzaki; Daichi Nagai; Eiji Ichimura; Rika Goda; Arihiro Tomura; Mikio Doi; Kiyohiro Nishikawa
Journal:  J Gastroenterol       Date:  2006-03       Impact factor: 7.527

Review 7.  Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models.

Authors:  Xi-Ling Jiang; Frank J Gonzalez; Ai-Ming Yu
Journal:  Drug Metab Rev       Date:  2010-09-21       Impact factor: 4.518

8.  Lung Epithelial CYP1 Activity Regulates Aryl Hydrocarbon Receptor Dependent Allergic Airway Inflammation.

Authors:  Francesca Alessandrini; Renske de Jong; Maria Wimmer; Ann-Marie Maier; Isis Fernandez; Miriam Hils; Jeroen T Buters; Tilo Biedermann; Ulrich M Zissler; Christian Hoffmann; Julia Esser-von-Bieren; Carsten B Schmidt-Weber; Caspar Ohnmacht
Journal:  Front Immunol       Date:  2022-06-06       Impact factor: 8.786

9.  Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.

Authors:  H C Liang; H Li; R A McKinnon; J J Duffy; S S Potter; A Puga; D W Nebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

10.  Sheep lung cytochrome P4501A1 (CYP1A1): cDNA cloning and transcriptional regulation by oxygen tension.

Authors:  T A Hazinski; E Noisin; I Hamon; A DeMatteo
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.